Target Gene/Pathway Pathway / Gene


Search results


No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related
KEGG GENES KEGG DRUG DrugBank Disease ID
1 Bladder cancer 💬
[1] BRAF 💬 D10064 💬 Dabrafenib [1] 34 💬
2 Bladder cancer 💬
[2] BRAF, RAF1 💬 D08524 💬 Sorafenib [2] 34, 86 💬
3 Bladder cancer 💬
[1] CDK4 💬 D10688 💬 Abemaciclib [1] 34 💬
4 Bladder cancer 💬
[1] EGFR 💬 D03455 💬 Cetuximab [2] 51, 86 💬
5 Bladder cancer 💬
[1] EGFR 💬 D07907 💬 Erlotinib [1] 94 💬
6 Bladder cancer 💬
[1] EGFR 💬 D01977 💬 Gefitinib [1] 75 💬
7 Bladder cancer 💬
[1] EGFR 💬 D11251 💬 Icotinib [1] 34 💬
8 Bladder cancer 💬
[2] EGFR, ERBB2 💬 D08108 💬 Lapatinib [3] 34, 74, 75 💬
9 Bladder cancer 💬
[2] EGFR, ERBB2 💬 D08950 💬 Neratinib [1] 34 💬
10 Bladder cancer 💬
[2] EGFR, ERBB2 💬 D11772 💬 Tesevatinib [1] 67 💬
11 Bladder cancer 💬
[1] FGFR3 💬 D11589 💬 Infigratinib [1] 276 💬
12 Bladder cancer 💬
[1] FGFR3 💬 D10481 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
13 Bladder cancer 💬
[2] MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib [1] 34 💬
14 Bladder cancer 💬
[2] MAP2K1, MAP2K2 💬 D10405 💬 Cobimetinib [1] 280 💬
15 Bladder cancer 💬
[2] MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib [1] 34 💬
16 Bladder cancer 💬
[2] MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib [1] 34 💬
17 Bladder cancer 💬
[2] MAP2K1, MAP2K2 💬 D10175 💬 Trametinib [4]  2 , 34, 279, 280 💬
18 Bladder cancer 💬
[1] SRC 💬 D03252 💬 Bosutinib [2]  2 , 67 💬
19 Bladder cancer 💬
[1] SRC 💬 D03658 💬 Dasatinib [2] 51, 85 💬
20 Bladder cancer 💬
[1] SRC 💬 D06414 💬 Dasatinib [2] 51, 85 💬
21 Bladder cancer 💬
[1] SRC 💬 D09664 💬 Saracatinib [3]  6 , 89, 272 💬
22 Bladder cancer 💬
[1] VEGFA 💬 D09574 💬 Aflibercept [2] 90, 166 💬
23 Bladder cancer 💬
[1] VEGFA 💬 D06409 💬 Bevacizumab [6] 13, 34, 85, 87, 227, 280 💬
24 Bladder cancer 💬
[1] VEGFA 💬 D05697 💬 Ranibizumab [4] 34, 166, 227, 301 💬